FOXM1 is overexpressed in many human cancers and is associated with a poor prognosis, such as breast, oral cavity squamous cell carcinoma, head and neck, bladder, esophageal and colorectal cancers [24, 26, 46, 47, 48, 49]. This evidence concerns the gene FOXM1 and cancer.